Pascal Viguié is a co-founder and CEO of ByoRNA, focusing on making mRNA therapies accessible to more people. After transitioning from a successful career in the digital sector, Pascal returned to academia to pursue a master's degree in Nanotechnology for Medicine and Health Care at the University of Oxford. With a background in finance and entrepreneurship, including roles such as CEO of 321Auto.com and investor in various startups, Pascal is committed to revolutionizing bioproduction to improve outcomes for patients with cancer and rare diseases. Pascal's educational journey includes degrees from prestigious institutions like Columbia University and Ecole polytechnique, and a history of significant investments in innovative companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices